一种分子接方法来控制基于CRISPR的技术的半衰期
Vedagopuram Sreekanth1,2,3, Max Jan4,5,6, Kevin T Zhao7,8,9
1Chemical Biology and Therapeutics Science Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts 02142, United States.
Journal of the American Chemical Society
|June 30, 2025
概括
科学家开发了一种新方法来控制CRISPR基因编辑工具的寿命, 这一突破为更安全的治疗应用提供了精确的开/关功能.
科学领域:
- 生物技术
- 分子生物学
- 基因编辑技术
背景情况:
- 基准编辑器和CRISPRi等基于CRISPR的技术是强大的工具, 但对于治疗应用需要精确的半衰期控制.
- 目前控制Cas9核酶半衰期的方法效率低下,速度缓慢,不适合体内使用.
- 控制CRISPR活动的持续时间对于尽量减少非目标效应和潜在的不良事件在临床环境中至关重要.
研究的目的:
- 开发一个通用和高效的平台来控制基于CRISPR技术的半衰期.
- 为了实现CRISPR活动的精确开启/关闭和微调,
- 为了证明这种半衰期控制系统的体内适用性.
主要方法:
- 使用利胺分子粘合剂与基于CRISPR的技术连接泛素酶复合物.
- 具有响应元件的工程CRISPR工具,可在玛利多米德结合时促进无处不在和降解.
- 在大型CRISPR技术 (基编辑器,CRISPRi) 和小型反CRISPR蛋白质上测试该平台.
主要成果:
- 通过使用波马利多米德成功控制了各种基于CRISPR的技术的半衰期.
- 展示了基础编辑器"开启"的第一个例子,使其能够精确控制其活动和特异性.
- 通过腺相关病毒 (AAV) 输送,表现出基基编辑器活性的体内控制,由于反应元素小且药物特性有利.
结论:
- 这种基于利胺的平台提供了一种可通用的方法来精确控制CRISPR技术的半衰期.
- 这种方法有助于微调CRISPR活性,提高治疗应用的安全性和有效性.
- 开发的方法和试剂在推动基于CRISPR技术的治疗发展方面取得了重大进展.
相关概念视频
01:59CRISPR
53.0K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
53.0K
02:53Conservative Site-specific Recombination and Phase Variation
6.1K
Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
The recognition sites for Cre recombinase called LoxP...
6.1K
01:28CRISPR/Cas9 Genome Editing
343
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
343
02:31Homologous Recombination
52.6K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
52.6K
02:53CRISPR and crRNAs
17.4K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
17.4K